journal article·2023-07-05

Mitochondria-Targeted Thymidylate Synthase Inhibitor Based on Fluorescent Molecularly Imprinted Polymers for Tumor Antimetabolic Therapy

Yu-Sheng Feng, Ya-Ting Qin, Ji Zhuang, Yao-Jia Ma, Xi-Wen He, Wen-You Li, Yu-Kui Zhang

ACS Applied Materials & Interfaces· Volume 15· Issue 26
Publisher page

Abstract

Antimetabolites targeting thymidylate synthase (TS), such as 5-fluorouracil and capecitabine, have been widely used in tumor therapy in the past decades. Here, we present a strategy to construct mitochondria-targeted antimetabolic therapeutic nanomedicines based on fluorescent molecularly imprinted polymers (FMIP), and the nanomedicine was denoted as Mito-FMIP. Mito-FMIP, synthesized using fluorescent dye-doped silica as the carrier and amino acid sequence containing the active center of TS as the template peptide, could specifically recognize and bind to the active site of TS, thus inhibiting the catalytic activity of TS, and therefore hindering subsequent DNA biosynthesis, ultimately inhibiting tumor growth. The imprinting factor of FMIP reached 2.9, and the modification of CTPB endowed Mito-FMIP with the ability to target mitochondria. In vitro experiments demonstrated that Mito-FMIP was able to efficiently aggregate in mitochondria and inhibit CT26 cell proliferation by 59.9%. The results of flow cytometric analysis showed that the relative mean fluorescence intensity of Mito-FMIP accumulated in the mitochondria was 3.4-fold that of FMIP. In vivo experiments showed that the tumor volume of the Mito-FMIP-treated group was only one third of that of the untreated group. In addition, Mito-FMIP exibited the maximum emission wavelength at 682 nm, which allowed it to be used for fluorescence imaging of tumors. Taken together, this study provides a new strategy for the construction of nanomedicines with antimetabolic functions based on molecularly imprinted polymers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Analytical chemistry methods development · Carbon and Quantum Dots Applications · Medical Imaging and Pathology Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Sciences, College of Chemistry, Nankai University, Tianjin 300071, China

ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou 311200, China

National Chromatographic Research and Analysis Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China

Funding

Natural Science Foundation of Tianjin City · Open Research Fund of State Key Laboratory of Bioelectronics · National Natural Science Foundation of China

References (54)

Show source-provided references
1. 10.1021/acs.chemrev.7b0077510.1021/acs.chemrev.7b00775 ↗
2. 10.1016/j.chembiol.2017.08.02810.1016/j.chembiol.2017.08.028 ↗
3. 10.3390/pharmaceutics1105019910.3390/pharmaceutics11050199 ↗
4. 10.4161/cbt.7.7.618110.4161/cbt.7.7.6181 ↗
5. 10.1016/j.biopha.2021.11128510.1016/j.biopha.2021.111285 ↗
6. 10.1016/j.mam.2016.11.00510.1016/j.mam.2016.11.005 ↗
7. 10.3389/fcell.2021.63330510.3389/fcell.2021.633305 ↗
8. 10.1007/s12032-022-01864-z10.1007/s12032-022-01864-z ↗
9. 10.1038/nrclinonc.2014.5110.1038/nrclinonc.2014.51 ↗
10. 10.1038/179663a010.1038/179663a0 ↗
11. 10.1111/cas.1453210.1111/cas.14532 ↗
12. 10.2174/156802661566615091511193310.2174/1568026615666150915111933 ↗
13. 10.1172/JCI14855010.1172/JCI148550 ↗
14. 10.2147/IJN.S25770010.2147/IJN.S257700 ↗
15. 10.1002/1878-0261.1322710.1002/1878-0261.13227 ↗
16. 10.1021/cr900028p10.1021/cr900028p ↗
17. 10.1016/j.pharmthera.2019.10744710.1016/j.pharmthera.2019.107447 ↗
18. 10.1186/s40959-019-0048-310.1186/s40959-019-0048-3 ↗
19. 10.1007/s11883-018-0702-510.1007/s11883-018-0702-5 ↗
20. 10.3390/cancers1007024010.3390/cancers10070240 ↗
21. 10.1039/c7cs00854f10.1039/c7cs00854f ↗
22. 10.1002/smll.20190664410.1002/smll.201906644 ↗
23. 10.1039/d1ay00067e10.1039/d1ay00067e ↗
24. 10.1016/j.trac.2021.11641410.1016/j.trac.2021.116414 ↗
25. 10.1002/cjoc.20210067910.1002/cjoc.202100679 ↗
26. 10.1002/anie.20210665710.1002/anie.202106657 ↗
27. 10.1002/adma.20180632810.1002/adma.201806328 ↗
28. 10.1016/j.tibtech.2019.10.00210.1016/j.tibtech.2019.10.002 ↗
29. 10.1016/j.bios.2020.11246410.1016/j.bios.2020.112464 ↗
30. 10.1016/j.jece.2021.10706910.1016/j.jece.2021.107069 ↗
31. 10.1016/j.tifs.2021.03.00310.1016/j.tifs.2021.03.003 ↗
32. 10.1021/acsnano.1c0716610.1021/acsnano.1c07166 ↗
33. 10.1021/acs.analchem.0c0447410.1021/acs.analchem.0c04474 ↗
34. 10.1021/acsami.2c1773110.1021/acsami.2c17731 ↗
35. 10.1002/adfm.20200393410.1002/adfm.202003934 ↗
36. 10.1039/d2tb00680d10.1039/d2tb00680d ↗
37. 10.1002/adma.20200777810.1002/adma.202007778 ↗
38. 10.1016/j.cclet.2022.02.04710.1016/j.cclet.2022.02.047 ↗
39. 10.1016/j.addr.2020.09.01010.1016/j.addr.2020.09.010 ↗
40. 10.1021/acsami.0c0614410.1021/acsami.0c06144 ↗
41. 10.1021/ja303931b10.1021/ja303931b ↗
42. 10.1186/s12645-022-00120-310.1186/s12645-022-00120-3 ↗
43. 10.1111/cas.1462410.1111/cas.14624 ↗
44. 10.1007/s00604-020-4198-710.1007/s00604-020-4198-7 ↗
45. 10.1016/j.scib.2021.10.00610.1016/j.scib.2021.10.006 ↗
46. 10.1002/advs.20210171310.1002/advs.202101713 ↗
47. 10.1021/acsnano.1c0800810.1021/acsnano.1c08008 ↗
48. 10.1002/anie.20190169910.1002/anie.201901699 ↗
49. 10.1002/anie.20201295610.1002/anie.202012956 ↗
50. 10.1016/j.foodchem.2022.13227510.1016/j.foodchem.2022.132275 ↗
51. 10.1016/j.bios.2021.11354210.1016/j.bios.2021.113542 ↗
52. 10.1039/c9nr04655k10.1039/c9nr04655k ↗
53. 10.1002/smll.20220645310.1002/smll.202206453 ↗
54. 10.1002/advs.20220203810.1002/advs.202202038 ↗